SK biosciences plans to launch the SKYZoste For Shingles with proven efficacy and safety in SEA South Korea headquartered SK bioscience, a global innovative vaccine, and the biotech company has received a biologics license application approval for the SKYZoster from the National Pharmaceutical Regulatory Agency (NPRA) in Malaysia. The Ministry of F
1348 Reached3 Comments
Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments
Woman presented with Fever of Unknown Origin
7720 Reached93 Comments19 Likes
How Physicians Should Manage Stress?
35294 Reached152 Comments203 Likes
Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes
Rubella Syndrome in Neonate
1399 Reached12 Comments9 Likes